Advertisement

Topics

Medtronic CoreValve(TM) Evolut(TM) R System First TAVI to Receive CE Mark for Intermediate Risk Aortic Stenosis Patients

13:00 EDT 1 Aug 2016 | GlobalNewsWire (2014)

This article has expired, however you can still download the PDF.
Preview:
Next-Generation Recapturable Device is the First-of-its-Kind Approved in Europe to Treat Intermediate Risk Patients as an Alternative to Open-Heart Surgery DUBLIN - August 1, 2016 - Medtronic plc (NYSE: MDT) today announced CE (Conformité Europ...

Other Sources for this Article

NEXT ARTICLE

More From BioPortfolio on "Medtronic CoreValve(TM) Evolut(TM) R System First TAVI to Receive CE Mark for Intermediate Risk Aortic Stenosis Patients"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...

Cardiology
Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...